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different de novo lesions in the same vessel within a distance enough to allow the
deployment of two non-overlapped stents and with similar morphological features.
Each lesion was treated with each drug-eluting stent in a randomized location. Patients
were evaluated at 12 months with an OFDI system. Off-line analysis of the continuous
cross-sections within the stented segment was performed at 1 mm intervals. The strut
apposition and neointimal coverage were assessed for each strut.
Results: A total of 30 patients were included (age 69±7 yrs, 33% diabetics, 60%
unstable angina, 40% stable angina). At 12 months 30 PES (length 18.1±8 mm and
diameter 2.57±0,3 mm) were examined analyzing 154±90 struts and 30 EES (length
16.4±5 mm and diameter 2.65±0,3 mm) analyzing 158±72 struts. The proportion of
non-covered struts was 1.5±2.9 % in PES and 0.8±1.3% in EES (p=0.2). The rate of
malapposition among non-covered struts was 58% in PES and 22.5% in EES
(p=0.0017) being the maximal malapposition area significantly larger with PES (0.6±
0.3 vs. 0.25± 0.2 mm2, p=0.001).
Conclusion: In very similar conditions, same patient, same artery and similar lesions
EES show a trend towards a greater degree of intimal coverage at one year follow up
compared to PES and a significant lower rate of malapposed non covered struts. These
findings suggest that very late thrombosis rate could be lower with EES as opposed to
PES.
TCT-625
Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap
segments in drug-eluting stents 9-13 months after implantation: in vivo-
assessment with optical coherence tomography
Juan Luis Gutiérrez-Chico1, Lorenz Räber2, Evelyn Regar1, Takayuki Okamura1,
Carlo di Mario3, Stephan Windecker2, Gerrit-Anne van Es4, Patrick W Serruys1
1Erasmus Medical Center - Thoraxcenter, Rotterdam, Netherlands; 2Swiss Heart
Center, Inselspital, Bern, Switzerland; 3Cardiovascular Biomedical Research Unit,
Royal Brompton and Harefield NHS Trust, London, United Kingdom; 4Cardialysis
BV, Rotterdam, Netherlands
Background: Although histologic experimental studies have reported delayed
neointimal healing in overlap compared to non-overlap segments in drug-eluting stents
(DES), these observations have not been confirmed in human coronary arteries hitherto.
On the contrary, angiographic and optical coherence tomography (OCT) studies suggest
that DES overlap elicits rather an exaggerated than an incomplete neointimal reaction.
We compare the coverage of overlap vs. non-overlap segments of the same lesion in
DES using OCT and accounting for eventual heterogeneity of the effect.
Methods: OCT studies from 2 randomized trials (NCT00617084, NCT00389220)
comparing different drug-eluting stents were analyzed at 9-13 months follow-up.
Coverage of struts in overlapping segments was compared vs. the corresponding non-
overlapping segments of the same stents, using statistical pooled analysis.
Results: 178 stents implanted in 99 patients were finally analyzed: 38 sirolimus-eluting
(SES), 33 biolimus-eluting (BES), 57 everolimus-eluting (EES) and 50 zotarolimus-
eluting stents (ZES); 34120 struts. The risk-ratio for non-coverage was 2.35 (95% CI:
1.86 – 2.98) in overlapping vs. non-overlapping segments. Thickness of coverage in
overlaps was only 85% (95% CI: 81 – 90%) of the thickness in non-overlaps.
Significant heterogeneity of the effect was observed, especially pronounced in the
comparison of thickness of coverage (I2=90.31).
Conclusion: DES struts in overlapping segments are at higher risk of incomplete tissue
coverage and are covered by a thinner neointimal layer than the struts in the
corresponding non-overlapping distal and proximal segments of the same stents at 9-
13 months. Although an average greater neointimal inhibition is observed in overlaps,
the neointimal reaction is subjected to pronounced interindividual variations.
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Background: The aim of this study is to evaluate the impact of inflammatory status
and surrogate marker levels of cholesterol metabolism on plaque vulnerability.
Methods: This study designed to enroll 80 stable angina pectoris patients. Non-culprit
vessels with more than 25% diameter stenosis by visual estimation were imaged with
a 20 MHz phased-array intravascular ultrasound (VH-IVUS) catheter (motorized pull-
back system at 0.5 mm/s) and optical coherence tomography (OCT) wire (motorized
pull-back system at 1 mm/s and analyzed at 0.3mm interval). Definite-fibroatheroma
(D-FA) was defined as 1) percent necrotic core area >20% in contact with the lumen
in VH-IVUS; 2) percent plaque plus media cross-sectional area >40% in VH-IVUS;
3) fibrous cap thickness at the thinnest part <65μm in OCT.
Results: High-sensitivity C-reaction protein (hsCRP), low-density lipoprotein (LDL)
cholesterol, campesterol, and the ratio of campesterol to lathosterol were significantly
positive correlation with percent necrotic core volume (%NCV). On the other hand,
lathosterol was significantly negative correlation with %NCV (table). In subgroup
divided by the incidence of D-FA, hsCRP, campesterol, and the ratio of campesterol
to lathosterol were significantly lower in no D-FA group (515±270 vs.967±457 ng/ml;
p=0.004, 159.2±83.3 vs. 218.5±92.4 μg/100mg total cholestenol; p=0.01, 1.82±1.01
vs. 3.50±1.50; p<0.0001), however lathosterol was significantly higher (96.1±44.2 vs.
68.5±29.3 μg/100mg total cholestenol; p=0.007).
Correlation cholesterol synthesis and absorption with percent necrotic core
volume
Conclusion: Higher inflammatory status, enhanced absorption, and reduced synthesis
of cholesterol may be related to plaque vulnerability.
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Background: Slow flow or no re-flow phenomenon is mainly induced by distal
embolization during PCI and is associated with unfavorable long-term clinical
outcomes. Various imaging modalities have failed to detect high risk patients of distal
embolization for whom distal protection might be beneficial. The object of this study
is to examine the frequency of distal embolization using filter-type distal protection
device and to clarify the predicting factors of distal embolization.
Methods: Consecutive patients (n=98) with or without ACS who received PCI with
filter-type distal protection device (Filtrap) and successful angioscopic and VH-IVUS
examination of target lesion were prospectively enrolled. Presence of yellow plaque
and plaque rupture were evaluated by angioscopy; and tissue classification and plaque
burden were evaluated by VH-IVUS. Distal embolization was evaluated by the
pathological examination of collected material in the filter device.
Results: Distal embolizatioin of thrombus tended to be frequent in ACS than in non
ACS patients (81.03% vs. 65%, P=0.074). That of plaque debris was more frequent in
ACS than non-ACS patients (48.28% vs. 25%, P<0.05). Distal embolization of plaque
debris was more frequent in the patients with rupured plaque than in those without it
(85.7% vs. 12.3%, p<0.05), in the patients with yellow plaque than in those without it
(50.7% vs. 7.0%, P<0.05), and tended to be more frequent in the patients with large
(>75%) plaque burden than in those without it (46.3% vs. 29.5%, p=0.09). Remarkably,
94% of patients with ruptured plaque and large plaque burden had distal embolization
of plaque debris.
Conclusion: Distal embolization of plaque debris was detected frequently in the
patients with ruptured yellow plaque and large plaque burden. Using both anigoscopy
and VH-IVUS before procedure, we may predict distal embolization. Filter-type distal
protection device would be potentially beneficial for those high risk patients.
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Background: In drug-eluting stents, a fixed loading dose per metal area may result in
considerable variability in actual dose exposed to vessel wall due to differences in strut
spacing once expanded in varying sizes of lesions. This study aimed to evaluate
potential effects of different dose intensity, as estimated by 3D-IVUS dosimetry, on
vascular response after Resolute zotarolimus-eluting stent (ZES) implantation.
Methods: Serial (baseline and 8-9 mo) 3D-IVUS was performed in 121 lesions treated
with a single Resolute ZES. Neointimal obstruction was calculated as neointima/stent
volume. Cross sectional narrowing (CSN) was defined as neointima/stent area. In each
lesion, exposed dose intensity was calculated as known loading dose/measured stented
segment surface area at post-procedure. Lesions were divided into tertiles based on the
dose intensity.
Results: The exposed dose intensity ranged from 0.76 to 1.58 μg/mm2 (1.08±0.18
μg/mm2). The low dose group showed a trend toward slightly greater neointima.
However, neointimal obstruction, max CSN, neointimal thickness, vessel remodeling,
and the incidence of late incomplete stent apposition were not significantly different
among the 3 groups.
Conclusion: Detailed 3D-IVUS dosimetry revealed a significant lesion-to-lesion
variability in dose intensity exposed to vessel wall following Resolute ZES
implantation. However, Resolute appears to yield equally effective neointimal
suppression and no evidence of adverse local vessel response, regardless of the varying
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dose intensity.
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Comparison of Optical Coherence Tomography and Histopathology Findings
Following Paclitaxel-Coating Balloon in Porcine In-stent Stenosis Model
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Background: Paclitaxel-Coating balloon (PCB) has shown efficacy for treatment of
coronary artery disease. Optical coherence tomography (OCT) is a promising
endovascular imaging devise and has been reported to have a high correlation with
histomorphometric measurement. However, the association of in-stent stenosis (ISR)
by OCT and histopathology response is still not fully addressed. The current study was
designed to compare the OCT and histopathological findings following PCB treatment
in a porcine ISR model.
Methods: Thirty-two coronary arteries (LAD: n=12, LCX: n=11, RCA: n=9) of 24
Yorkshire pigs were assigned to two (2) groups randomly. PCB (SeQuent, length
20mm, n=16) or non-coating balloon (NCB, length 20mm n=16) were inflated for 60
seconds with B:A 1.2:1 followed by BMS (length 12mm) implantation (S/A 1.5:1)
within the target region. At 28 days, animals underwent OCT and histopathology
evaluation.
Results: There were no significant differences between groups among parameters
measured by OCT. The thickness of neointimal hyperplasia on stent strut and the
percent of ISR were 585 ± 277 μm, 46.8 ± 19.0 % for PCB, and 661 ± 237 μm, 52.4
± 15.3 % for NCB (p=NS, respectively). However, inflammation (PEB: 3.40 ± 0.84,
NCB: 2.27 ± 1.18, p=0.003) and fibrin deposition scores (PCB: 2.31 ± 0.93, NCB:
0.81 ± 0.86, p<0.001) were significantly higher in PCB compared to NCB. The OCT
ISR% was positively correlated with inflammation score (PCB: r=0.62, and NCB:
r=0.85; p<0.05 respectively). Interestingly, fibrin deposition score only in PCB was
negatively correlated with the OCT ISR% (r=-0.68, p=0.005). OCT also showed an
uncovered (33.3%) and insufficient non-uniformed neointima (13.3%) in PCB group
(p=0.008 vs NCB).
Conclusion: OCT can be used as a valuable imaging tool to evaluate vessel wall
histopathological changes in vivo. The higher inflammation and fibrin deposition
scores in PCB may indicate a delayed healing response in the current experimental
setting.
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Background: The postprandial hyperglycemia is well known as one of the risk factors
for cardiovascular disease. Serum 1,5-Anhydroglucitol (1,5-AG) is a useful clinical
marker for short-term glycemic status and postprandial hyperglycemia. We examined
whether serum 1,5-AG level can predict the presence of coronary plaque.
Methods: We investigated the relationship between serum 1,5-AG level and coronary
plaque in 513 consecutive patients evaluated by 128-slice CT. In those patients, 126
cases have taken coronary artery angiography (CAG). We compared the presence of
coronary plaque by MSCT and Syntax score of patients with CAG between patients
with serum 1,5-AG level less than 14μg/ml and over 14μg/ml.
Results: The table has shown in table. The level of serum 1,5-AG seems to have the
correlation and severity of coronary artery plaque/stenosis.
Conclusion: Our findings demonstrate that the relationship between the presence of
coronary plaque and serum 1,5-AG level was much better than that of HbA1c.
Measurement of serum 1,5-AG level might help to diagnose the presence of coronary
artery plaque in routine clinical practice.
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Correlation between modification in plaque composition and changes in
vascular geometry at the edges of bare metal and drug-eluting stents
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Background: To the present, little is known about the correlation between
modifications in plaque composition at stent edges and the changes in vessel geometry.
This study sought to evaluate, by serial grey-scale intravascular ultrasound (IVUS)
and Virtual Histology™, the modifications in plaque composition at the edges of drug-
eluting (DES) and bare-metal stents (BMS) and the correlation of these findings with
changes in the measuremntes of vessel, lumen and plaque area at those segments.
Methods: Single-center, prospective and randomized (1:1) evaluation of 40 patients
with acute coronary syndrome treated with BMS (Driver, n=20 patients) or DES
(Cypher, n=20 patients). Following stent deployment, all individuals underwent gray
scale IVUS and Virtual Histology™ evaluation, which were repeated at nine months.
Primary endpoint was the modification in vessel, lumen and plaque area and in the
composition of the plaque in the mean time between the baseline and follow-up
procedure. Additionally, we sought to correlate the variation in plaque composition
and changes in vessel geometry.
Results: Baseline clinical and angiographic characteristics did not differ between
groups. At the proximal edge of DES and BMS there was a trend to positive vessel
remodeling which compensated the modest increase in plaque area. At the distal edge,
patients treated with DES had less plaque growth resulting in a larger lumen area at
follow-up. By Virtual Histology, there was a marked reduction in the % of fibrotic
tissue and necrotic core in both edges of the two stents and a positive, strong correlation
was seen between increase in % of fibrofatty component and augmentation in plaque
area (r=0.78, p=0.01).
Conclusion: The use of DES was not associated with “edge effect”. On the contrary,
patients treated with these devices experienced less plaque growth, especially at the
distal edge of the stents. Modifications in plaque composition, with increase in
fibrofatty content, might partially explain these findings.
TCT-632
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Neointimal Distribution by Optical Coherence Tomography
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Background: TAXUS Express™ paclitaxel-eluting stent (PES) and TAXUS Liberté™
PES consist of the same drug, drug dose, and polymer, but have different stent
platforms. TAXUS Liberté™ PES has a thinner stent strut platform specifically
designed for more uniform drug elution. The aim of this study was to assess the impact
of stent design and strut thickness on vessel healing after PES deployment.
Methods: Fifty-four patients who underwent 6-month follow-up optical coherence
tomography (OCT) after TAXUS Express™ (n=27) or TAXUS Liberté™ PES (n=27)
implantation were enrolled. In addition to standard OCT variables, longitudinal and
circumferential uniformity of neointimal distribution was evaluated in 3-dimensions
by computing mean neointimal thickness (NIT) within 360 equally-spaced radial
sectors for every 1-mm cross-section along the stented segment. The incidence of stents
with a peri-strut low intensity area (PLIA), a finding suggestive of delayed arterial
healing, was also evaluated.
Results: TAXUS Liberté™ PES had a significantly thinner mean NIT than the TAXUS
Express™ PES with comparable frequency of uncovered struts. Longitudinal and
circumferential absolute variation of NIT expressed by standard deviation of NIT
calculated from each sector was significantly smaller for the TAXUS Liberté™ PES
than for the TAXUS Express™ PES. TAXUS Liberté™ PES had a tendency toward a
decreased incidence of thrombus and struts with PLIA than the TAXUS Express™
PES.
Comparisons between TAXUS Liberté PES vs. TAXUS Express PES
Conclusion: Stent design and thickness appeared to impact vessel healing of PES. The
stent platform of TAXUS Liberté™ PES may offer greater and more homogeneous
neointima suppression in patients treated with PES.
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